IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 103 filers reported holding IMMUNOMEDICS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,846,000 | +969.6% | 245,160 | +345.7% | 0.23% | +904.3% |
| Q2 2020 | $1,949,000 | +289.8% | 55,000 | +132.4% | 0.02% | +666.7% |
| Q4 2019 | $500,000 | +151.3% | 23,663 | +57.8% | 0.00% | +50.0% |
| Q3 2019 | $199,000 | -76.1% | 15,000 | -75.0% | 0.00% | -66.7% |
| Q2 2019 | $832,000 | +73.3% | 59,925 | +139.7% | 0.01% | +50.0% |
| Q1 2019 | $480,000 | -83.1% | 25,000 | -79.2% | 0.00% | -75.0% |
| Q2 2018 | $2,840,000 | +23.3% | 120,000 | -15.8% | 0.02% | +45.5% |
| Q4 2017 | $2,304,000 | -1.7% | 142,600 | -14.9% | 0.01% | -26.7% |
| Q3 2017 | $2,343,000 | -0.8% | 167,600 | -37.4% | 0.02% | -6.2% |
| Q2 2017 | $2,363,000 | +244.0% | 267,600 | +152.0% | 0.02% | +220.0% |
| Q1 2017 | $687,000 | +940.9% | 106,200 | +420.4% | 0.01% | – |
| Q3 2016 | $66,000 | -63.3% | 20,409 | -73.6% | 0.00% | – |
| Q2 2016 | $180,000 | – | 77,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |